Save $1151
Description
GAVRETO (pralsetinib) is a prescription medicine used to treat certain cancers caused by abnormal rearranged during transfection (RET) genes in:
- adults with non-small cell lung cancer (NSCLC) that has spread
- adults and children 12 years of age and older with advanced thyroid cancer or thyroid cancer that has spread who require a medicine by mouth or injection (systemic therapy) and who have received radioactive iodine and it did not work or is no longer working.
Additional information
| Brand | Gavreto |
|---|---|
| Generic name | Pralsetinib capsules |
| Form | Oral capsules |
| Strength | 100mg |
| Packing | 120 capsules |
| Manufacturer | Catalent CTS |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
Reviews
There are no reviews yet.